We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$112B
AUM Growth
+$9.72B
Cap. Flow
+$4.75B
Cap. Flow %
4.26%
Top 10 Hldgs %
20.07%
Holding
4,187
New
244
Increased
1,335
Reduced
1,929
Closed
426

Sector Composition

Rank Sector Weight
1 Technology 11.35%
2 Healthcare 10.59%
3 Financials 10.23%
4 Industrials 7.49%
5 Consumer Discretionary 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRNA
3451
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$245K ﹤0.01%
16,095
-4,126
-20% -$60.1K
HIBB
3452
DELISTED
Hibbett, Inc. Common Stock
HIBB
$245K ﹤0.01%
13,058
-5,263
-29% -$119K
RCKT icon
3453
Rocket Pharmaceuticals
RCKT
$340M
$244K ﹤0.01%
9,885
-7,605
-43% -$165K
BSM icon
3454
Black Stone Minerals
BSM
$3.18B
$243K ﹤0.01%
13,353
-4,534
-25% -$82.5K
GLOB icon
3455
Globant
GLOB
$1.58B
$243K ﹤0.01%
+4,107
New +$241K
TGTX icon
3456
TG Therapeutics
TGTX
$7.96B
$242K ﹤0.01%
43,241
-13,133
-23% -$150K
APLS
3457
DELISTED
Apellis Pharmaceuticals
APLS
$241K ﹤0.01%
13,569
-966
-7% -$17.9K
VTN icon
3458
Invesco Trust for Investment Grade New York Municipals
VTN
$159M
$241K ﹤0.01%
+19,288
New +$244K
XPRO icon
3459
Expro Ltd
XPRO
$1.79B
$241K ﹤0.01%
4,640
-3,267
-41% -$165K
TUSK icon
3460
Mammoth Energy Services
TUSK
$128M
$240K ﹤0.01%
8,220
-588,127
-99% -$19.4M
GNMK
3461
DELISTED
GenMark Diagnostics, Inc
GNMK
$240K ﹤0.01%
32,548
-10,268
-24% -$75.3K
BOTZ icon
3462
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.28B
$239K ﹤0.01%
+10,438
New +$233K
IGM icon
3463
iShares Expanded Tech Sector ETF
IGM
$10B
$239K ﹤0.01%
6,852
-156,066
-96% -$5.3M
TCRT icon
3464
Alaunos Therapeutics
TCRT
$4.59M
$237K ﹤0.01%
494
-251
-34% -$108K
CONN
3465
DELISTED
Conn's Inc.
CONN
$235K ﹤0.01%
6,645
-789
-11% -$28.2K
BBSI icon
3466
Barrett Business Services
BBSI
$959M
$234K ﹤0.01%
13,980
-19,116
-58% -$387K
LRMR icon
3467
Larimar Therapeutics
LRMR
$397M
$233K ﹤0.01%
1,659
-934
-36% -$113K
AMR
3468
DELISTED
Alta Mesa Resources Inc
AMR
$233K ﹤0.01%
55,854
+9,546
+21% +$52.3K
VSEC icon
3469
VSE Corp
VSEC
$5.45B
$231K ﹤0.01%
6,986
-2,418
-26% -$98.9K
ASRT
3470
DELISTED
Assertio
ASRT
$229K ﹤0.01%
647
-247
-28% -$108K
ARA
3471
DELISTED
American Renal Associates Holdings, Inc
ARA
$229K ﹤0.01%
10,533
-1,685
-14% -$31.9K
FMBH icon
3472
First Mid Bancshares
FMBH
$1.39B
$226K ﹤0.01%
5,584
-1,661
-23% -$67.7K
GBLI icon
3473
Global Indemnity Group
GBLI
$402M
$226K ﹤0.01%
5,998
-2,532
-30% -$98.7K
DSKE
3474
DELISTED
Daseke, Inc. Common Stock
DSKE
$225K ﹤0.01%
28,061
-11,880
-30% -$106K
ORIT
3475
DELISTED
Oritani Financial Corp. New
ORIT
$224K ﹤0.01%
14,407
-12,482
-46% -$201K

Similar funds

Credit Suisse's Q3 2018 Portfolio in Review

As of Q3 2018, Credit Suisse held 4,187 positions worth $112B, up 9.5% from $102B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Credit Suisse deployed $4.75B of net new capital in Q3 2018, opening 244 new positions and adding to 1,335 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,600,000 shares worth $109M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $281M trimmed.

  • Credit Suisse's largest Q3 2018 buy was Invesco Zacks Mid-Cap ETF: 1,600,000 shares worth $109M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $1.14B increase.
  • Credit Suisse's biggest Q3 2018 reduction was UnitedHealth, cutting an estimated $281M.
  • Credit Suisse fully exited KraneShares CSI China Internet ETF in Q3 2018, selling an estimated $137M.
  • Credit Suisse's ten largest holdings make up 20% of its $112B portfolio in Q3 2018.
  • Credit Suisse opened 244 new positions and closed 426 in Q3 2018.
  • Credit Suisse's portfolio value rose 9.5% quarter-over-quarter to $112B.

Based on Credit Suisse's 13F filing for Q3 2018, filed 13 Nov 2018.